Choate Investment Advisors Gsk PLC Transaction History

Choate Investment Advisors

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 04, 2021	BUY	$38.79 - $43.16 $35,298 - $39,275	910 Added 3.83%	24,690 $943,000
Q2 2021 Jul 30, 2021	SELL	$36.52 - $41.46 $8,764 - $9,950	-240 Reduced 1.0%	23,780 $947,000
Q3 2020 Oct 26, 2020	SELL	$38.11 - $42.99 $2,286 - $2,579	-60 Reduced 0.25%	24,020 $904,000
Q2 2020 Jul 23, 2020	SELL	$37.87 - $43.58 $146,178 - $168,218	-3,860 Reduced 13.82%	24,080 $982,000
Q1 2019 Apr 29, 2019	SELL	$38.57 - $42.69 $586,071 - $648,674	-15,195 Reduced 35.23%	27,940 $1.17 Million
Q4 2018 Feb 14, 2019	BUY	$37.8 - $42.69 $13,229 - $14,941	350 Added 0.82%	43,135 $1.65 Million
Q2 2018 Jul 30, 2018	SELL	$39.61 - $42.76 $7,922 - $8,552	-200 Reduced 0.47%	42,785 $1.73 Million
Q1 2018 May 04, 2018	SELL	$36.18 - $40.15 $10,854 - $12,045	-300 Reduced 0.69%	42,985 $0
Q4 2017 Feb 14, 2018	SELL	$35.34 - $41.9 $4,346 - $5,153	-123 Reduced 0.28%	43,285 $0
Q3 2017 Nov 14, 2017	BUY	$39.44 - $41.55 $1.71 Million - $1.8 Million	43,408	43,408 $0

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Choate Investment Advisors, based on Form 13F filings with the SEC.

Stay updated on Choate Investment Advisors with notifications on news.